Jim Ellis
Chief Scientific Officer Nocion Therapeutics, Inc.
Seminars
Thursday 24th September 2026
Selective Sodium Channel Blockade to Deliver Clinical Efficacy in Refractory Chronic Cough
11:00 am
- Selective local targeting of cough nociceptors to provide meaningful clinical outcomes in patients with refractory chronic cough
- Interpreting Phase 2b clinical data to understand exposure response relationships, tolerability & efficacy
- Achieving sufficient local exposure in lung tissue while avoiding systemic liability
- Human proof of concept for selective sodium channel blockade to de-risk respiratory ion channel development
Thursday 24th September 2026
Fireside Chat: Reflecting on Clinical Experience to Shape Next‑Generation Ion Channel Programs
2:00 pm
- Discussing how programs evolved in response to clinical data and operational realities
- Sharing insights gained through adaptation, iteration, and risk management during development
- Informing future discovery and development choices with experience-based perspective
